Nicotine enhances murine airway contractile responses to kinin receptor agonists via activation of JNK- and PDE4-related intracellular pathways

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Xu, Yuan ^a   Zhang, Yaping ^a   Cardell, Lars Olaf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROPHENYL) 1,7 DIETHYLPYRIDO[2,3 D]PYRIMIDIN 2(1H) ONE; ACETYLCHOLINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR; DES ARGININE 9 BRADYKININ; DEXAMETHASONE; ENDOTHELIN RECEPTOR AGONIST; ENZYME INHIBITOR; FORSKOLIN; HEXAMETHONIUM; MESSENGER RNA; MG624; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; PHOSPHODIESTERASE IV; SEROTONIN; SEROTONIN AGONIST; STRESS ACTIVATED PROTEIN KINASE; THEOPHYLLINE; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

AIRWAY HYPERRESPONSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION OF THE LUNGS, BRONCHI AND PLEURA; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRACHEA; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; MALE; MAP KINASE KINASE 4; MICE; MICE, INBRED BALB C; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NICOTINE; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION; TRACHEA;

EID: 77952540772     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-13     Document Type: Article

References (55)

1. Trigg CJ, Bennett JB, Tooley M, Sibbald B, D'Souza MF, Davies RJ. A general practice based survey of bronchial hyperresponsiveness and its relation to symptoms, sex, age, atopy, and smoking. Thorax 1990, 45(11):866-872. 10.1136/thx.45.11.866, 462785, 2256016.
2. Higgins BG, Britton JR, Chinn S, Lai KK, Burney PG, Tattersfield AE. Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sample. Thorax 1993, 48(9):899-905. 10.1136/thx.48.9.899, 464774, 8236072.
3. Menon P, Rando RJ, Stankus RP, Salvaggio JE, Lehrer SB. Passive cigarette smoke-challenge studies, increase in bronchial hyperreactivity. J Allergy Clin Immunol 1992, 89(2):560-566. 10.1016/0091-6749(92)90323-T, 1740586.
4. Janson C, Chinn S, Jarvis D, Zock JP, Toren K, Burney P. Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey, a cross-sectional study. Lancet 2001, 358(9299):2103-2109. 10.1016/S0140-6736(01)07214-2, 11784622.
5. Strachan D, Cook D. Health effects of passive smoking. 6. Parental smoking and childhood asthma, longitudinal and case-control studies. Thorax 1998, 53(3):204-212. 10.1136/thx.53.3.204, 1745164, 9659358.
6. Illi S, von Mutius E, Lau S, Nickel R, Niggemann B, Sommerfeld C, Wahn U. The pattern of atopic sensitization is associated with the development of asthma in childhood. J Allergy Clin Immunol 2001, 108(5):709-714. 10.1067/mai.2001.118786, 11692093.
7. Eisner MD, Klein J, Hammond SK, Koren G, Lactao G, Iribarren C. Directly measured second hand smoke exposure and asthma health outcomes. Thorax 2005, 60(10):814-821. 10.1136/thx.2004.037283, 1747192, 16192366.
8. Bergren DR. Chronic tobacco smoke exposure increases airway sensitivity to capsaicin in awake guinea pigs. J Appl Physiol 2001, 90(2):695-704.
9. Carlisle DL, Hopkins TM, Gaither-Davis A, Silhanek MJ, Luketich JD, Christie NA, Siegfried JM. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res 2004, 5:27. 10.1186/1465-9921-5-27, 544394, 15588326.
10. Vassallo R, Kroening PR, Parambil J, Kita H. Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Mol Immunol 2008, 45(12):3321-3329. 10.1016/j.molimm.2008.04.014, 18533267.
11. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421(6921):384-388. 10.1038/nature01339, 12508119.
12. Mishra NC, Rir-Sima-Ah J, Langley RJ, Singh SP, Pena-Philippides JC, Koga T, Razani-Boroujerdi S, Hutt J, Campen M, Kim KC, et al. Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J Immunol 2008, 180(11):7655-7663. 2614131, 18490768.
13. Tsai JR, Chong IW, Chen CC, Lin SR, Sheu CC, Hwang JJ. Mitogen-activated protein kinase pathway was significantly activated in human bronchial epithelial cells by nicotine. DNA Cell Biol 2006, 25(5):312-322. 10.1089/dna.2006.25.312, 16716121.
14. Fan Chung K. Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol 2006, 533(1-3):110-117. 10.1016/j.ejphar.2005.12.059, 16458289.
15. Billington CK, Le Jeune IR, Young KW, Hall IP. A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2008, 38(1):1-7. 10.1165/rcmb.2007-0171OC, 17673687.
16. Zhang J, Bui T, Xiang J, Lin A. Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain. Mol Cell Biol 2006, 26(4):1223-1234. 10.1128/MCB.26.4.1223-1234.2006, 1367190, 16449637.
17. Pearson GW, Earnest S, Cobb MH. Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals. Mol Cell Biol 2006, 26(8):3039-3047. 10.1128/MCB.26.8.3039-3047.2006, 1446939, 16581779.
18. Billington CK, Penn RB. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003, 4:2. 10.1186/rr195, 152647, 12648290.
19. Zhang Y, Adner M, Cardell LO. IL-1beta-induced transcriptional up-regulation of bradykinin B1 and B2 receptors in murine airways. Am J Respir Cell Mol Biol 2007, 36(6):697-705. 10.1165/rcmb.2005-0369OC, 17255557.
20. Zhang Y, Adner M, Cardell LO. Up-regulation of bradykinin receptors in a murine in-vitro model of chronic airway inflammation. Eur J Pharmacol 2004, 489(1-2):117-126. 10.1016/j.ejphar.2004.02.033, 15063163.
21. Barnes PJ. Bradykinin and asthma. Thorax 1992, 47(11):979-983. 10.1136/thx.47.11.979, 464122, 1465760.
22. Zhang Y, Adner M, Cardell LO. Glucocorticoids suppress transcriptional up-regulation of bradykinin receptors in a murine in vitro model of chronic airway inflammation. Clin Exp Allergy 2005, 35(4):531-538. 10.1111/j.1365-2222.2005.02207.x, 15836764.
23. Bachar O, Adner M, Uddman R, Cardell LO. Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways. Eur J Immunol 2004, 34(4):1196-1207. 10.1002/eji.200324569, 15048731.
24. Gotti C, Balestra B, Moretti M, Rovati GE, Maggi L, Rossoni G, Berti F, Villa L, Pallavicini M, Clementi F. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors. Br J Pharmacol 1998, 124(6):1197-1206. 10.1038/sj.bjp.0701957, 1565512, 9720791.
25. Lawson CJ, Homewood J, Taylor AJ. The Effects of L-glucose on memory in mice are modulated by peripherally acting cholinergic drugs. Neurobiol Learn Mem 2002, 77(1):17-28. 10.1006/nlme.2000.4001, 11749083.
26. Aoki M, Kobayashi M, Ishikawa J, Saita Y, Terai Y, Takayama K, Miyata K, Yamada T. A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1, 7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity. J Pharmacol Exp Ther 2000, 295(1):255-260.
27. Conti-Fine BM, Navaneetham D, Lei S, Maus AD. Neuronal nicotinic receptors in non-neuronal cells, new mediators of tobacco toxicity?. Eur J Pharmacol 2000, 393(1-3):279-294. 10.1016/S0014-2999(00)00036-4, 10771024.
28. Lindell G, Farnebo LO, Chen D, Nexo E, Rask Madsen J, Bukhave K, Graffner H. Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand J Gastroenterol 1993, 28(6):487-494. 10.3109/00365529309098254, 8322024.
29. Clunes LA, Bridges A, Alexis N, Tarran R. In vivo versus in vitro airway surface liquid nicotine levels following cigarette smoke exposure. J Anal Toxicol 2008, 32(3):201-207.
30. Carlisle DL, Liu X, Hopkins TM, Swick MC, Dhir R, Siegfried JM. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells. Pulm Pharmacol Ther 2007, 20(6):629-641. 10.1016/j.pupt.2006.07.001, 17015027.
31. Koshi R, Sugano N, Orii H, Fukuda T, Ito K. Microarray analysis of nicotine-induced changes in gene expression in a macrophage-like human cell line. J Periodontal Res 2007, 42(6):518-526. 10.1111/j.1600-0765.2007.00976.x, 17956464.
32. Berman AR, Togias AG, Skloot G, Proud D. Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholine. J Appl Physiol 1995, 78(5):1844-1852.
33. Eric J, Gabra BH, Sirois P. Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice. Br J Pharmacol 2003, 138(8):1589-1597. 10.1038/sj.bjp.0705207, 1573809, 12721115.
34. Huang TJ, Haddad EB, Fox AJ, Salmon M, Jones C, Burgess G, Chung KF. Contribution of bradykinin B(1) and B(2) receptors in allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med 1999, 160(5 Pt 1):1717-1723.
35. Kusser B, Braun A, Praun M, Illi S, von Mutius E, Roscher AA. Polymorphisms in the bradykinin B2 receptor gene and childhood asthma. Biol Chem 2001, 382(5):885-889. 10.1515/BC.2001.110, 11517947.
36. Roomans G, Vanthanouvong V, Dragomir A, Kozlova I, Wróblewski R. Effects of nicotine on intestinal and respiratory epithelium. J Submicrosc Cytol Pathol 2002, 34(4):381-388.
37. Birrell MA, Wong S, Catley MC, Belvisi MG. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 2008, 214(1):27-37. 10.1002/jcp.21158, 17541958.
38. Adcock IM, Chung KF, Caramori G, Ito K. Kinase inhibitors and airway inflammation. Eur J Pharmacol 2006, 533(1-3):118-132. 10.1016/j.ejphar.2005.12.054, 16469308.
39. Xu CB, Zheng JP, Zhang W, Zhang Y, Edvinsson L. Lipid-soluble smoke particles upregulate vascular smooth muscle ETB receptors via activation of mitogen-activating protein kinases and NF-kappaB pathways. Toxicol Sci 2008, 106(2):546-555. 10.1093/toxsci/kfn173, 18718921.
40. De Bie JJ, Hessel EM, Van Ark I, Van Esch B, Hofman G, Nijkamp FP, Van Oosterhout AJ. Effect of dexamethasone and endogenous corticosterone on airway hyperresponsiveness and eosinophilia in the mouse. Br J Pharmacol 1996, 119(7):1484-1490. 1915832, 8968559.
41. Trifilieff A, El-Hashim A, Bertrand C. Time course of inflammatory and remodeling events in a murine model of asthma, effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 2000, 279(6):L1120-1128.
42. Haddad EB, Fox AJ, Rousell J, Burgess G, McIntyre P, Barnes PJ, Chung KF. Post-transcriptional regulation of bradykinin B1 and B2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-alpha: modulation by dexamethasone. Mol Pharmacol 2000, 57(6):1123-1131.
43. Schmidlin F, Scherrer D, Landry Y, Gies JP. Glucocorticoids inhibit the bradykinin B2 receptor increase induced by interleukin-1beta in human bronchial smooth muscle cells. Eur J Pharmacol 1998, 354(1):R7-8. 10.1016/S0014-2999(98)00478-6, 9726641.
44. Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999, 402(6760 Suppl):B31-38. 10.1038/35037026, 10586893.
45. Schulze-Osthoff K, Ferrari D, Riehemann K, Wesselborg S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 1997, 198(1-3):35-49.
46. Barr J, Sharma CS, Sarkar S, Wise K, Dong L, Periyakaruppan A, Ramesh GT. Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells. Mol Cell Biochem 2007, 297(1-2):93-99. 10.1007/s11010-006-9333-1, 2758082, 17021677.
47. Gensch E, Gallup M, Sucher A, Li D, Gebremichael A, Lemjabbar H, Mengistab A, Dasari V, Hotchkiss J, Harkema J, et al. Tobacco smoke control of mucin production in lung cells requires oxygen radicals AP-1 and JNK. J Biol Chem 2004, 279(37):39085-39093. 10.1074/jbc.M406866200, 15262961.
48. Zhou Y, Ling EA, Dheen ST. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J Neurochem 2007, 102(3):667-678. 10.1111/j.1471-4159.2007.04535.x, 17403137.
49. Bergmann MW, Staples KJ, Smith SJ, Barnes PJ, Newton R. Glucocorticoid inhibition of granulocyte macrophage-colony-stimulating factor from T cells is independent of control by nuclear factor-kappaB and conserved lymphokine element 0. Am J Respir Cell Mol Biol 2004, 30(4):555-563. 10.1165/rcmb.2003-0295OC, 14527927.
50. Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 1993, 265(3):1213-1223.
51. Toward TJ, Broadley KJ. Chronic lipopolysaccharide exposure on airway function, cell infiltration, and nitric oxide generation in conscious guinea pigs: effect of rolipram and dexamethasone. J Pharmacol Exp Ther 2001, 298(1):298-306.
52. Sanz MJ, Cortijo J, Morcillo EJ. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacol Ther 2005, 106(3):269-297. 10.1016/j.pharmthera.2004.12.001, 15922015.
53. Ammit AJ, Hoffman RK, Amrani Y, Lazaar AL, Hay DW, Torphy TJ, Penn RB, Panettieri RA. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol 2000, 23(6):794-802.
54. Kaur M, Holden NS, Wilson SM, Sukkar MB, Chung KF, Barnes PJ, Newton R, Giembycz MA. Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 2008, 295(3):L505-514. 10.1152/ajplung.00046.2008, 18586957.
55. Li X, Zarinetchi F, Schrier RW, Nemenoff RA. Inhibition of MAP kinase by prostaglandin E2 and forskolin in rat renal mesangial cells. Am J Physiol 1995, 269(4 Pt 1):C986-991.